Tri-Vi-Sol 0.225 mg/mL / 35 mg/mL / 0.01 mg/mL Oral Solution
RxNorm 1537235

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1537235 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Tri-Vi-Sol 0.225 mg/mL / 35 mg/mL / 0.01 mg/mL Oral Solution.

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Ascorbic acid 35 mg/ML / cholecalciferol 0.01 mg/ML / vitamin A 0.225 mg/ML Oral Solution [Tri-Vi-Sol]
AUI:12362871
SY
Tri-Vi-Sol (vitamin A 0.225 mg/ML / vitamin C 35 mg/ML / vitamin D3 0.01 mg/ML) Oral Solution
AUI:11821601
SY
Tri-Vi-Sol (vitamin A 750 UNT/ML / vitamin C 35 mg/ML / cholecalciferol 400 UNT/ML) Oral Solution
AUI:11821603
PSN
Tri-Vi-Sol 0.225 mg/mL / 35 mg/mL / 0.01 mg/mL Oral Solution
AUI:11828399
SY
Vit-C 35 mg/ML / Cholecalciferol 0.01 mg/ML / Vitamin A 0.225 mg/ML Oral Solution [Tri-Vi-Sol]
AUI:11828846
SY
Vitamin C 35 mg/ML / Cholecalciferol 0.01 mg/ML / Vitamin A 0.225 mg/ML Oral Solution [Tri-Vi-Sol]
AUI:11828866

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Ascorbic acid 35 mg/ML / cholecalciferol 0.01 mg/ML / vitamin A 0.225 mg/ML Oral Solution [Tri-Vi-Sol]
(Atom ID: 12362871)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin A 0.225 MG/ML Oral Solution [Tri-Vi-Sol]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1537235
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12362871
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1537235
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{2270553} 2418
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{2279008} 11246
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{336611} 1151
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{2270553} 2418
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{2279008} 11246
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{336611} 1151
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2270553} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{2279008} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{336611} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
07/29/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Sol
The RxTerm dose form name for this drug

SY

Synonym (SY):
Tri-Vi-Sol (vitamin A 0.225 mg/ML / vitamin C 35 mg/ML / vitamin D3 0.01 mg/ML) Oral Solution
(Atom ID: 11821601)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Tri-Vi-Sol (vitamin A 0.225 MG/ML / vitamin C 35 MG/ML / vitamin D3 0.01 MG/ML) Oral Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1537235
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11821601
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1537235
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
Tri-Vi-Sol (vitamin A 750 UNT/ML / vitamin C 35 mg/ML / cholecalciferol 400 UNT/ML) Oral Solution
(Atom ID: 11821603)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Tri-Vi-Sol (vitamin A 750 UNT/ML / vitamin C 35 MG/ML / cholecalciferol 400 UNT/ML) Oral Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1537235
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11821603
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1537235
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

PSN

Prescribable Name (PSN):
Tri-Vi-Sol 0.225 mg/mL / 35 mg/mL / 0.01 mg/mL Oral Solution
(Atom ID: 11828399)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Tri-Vi-Sol 0.225 MG/mL / 35 MG/mL / 0.01 MG/mL Oral Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1537235
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11828399
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1537235
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
Vit-C 35 mg/ML / Cholecalciferol 0.01 mg/ML / Vitamin A 0.225 mg/ML Oral Solution [Tri-Vi-Sol]
(Atom ID: 11828846)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
vit-C 35 MG/ML / Cholecalciferol 0.01 MG/ML / Vitamin A 0.225 MG/ML Oral Solution [Tri-Vi-Sol]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1537235
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11828846
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1537235
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
Vitamin C 35 mg/ML / Cholecalciferol 0.01 mg/ML / Vitamin A 0.225 mg/ML Oral Solution [Tri-Vi-Sol]
(Atom ID: 11828866)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
vitamin C 35 MG/ML / Cholecalciferol 0.01 MG/ML / Vitamin A 0.225 MG/ML Oral Solution [Tri-Vi-Sol]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1537235
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
11828866
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1537235
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Vitamin C



[Learn More]


Vitamin D



[Learn More]


* Please review the disclaimer below.